Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.

This report contains market size and forecasts of Anti-inflammatory Therapeutics in Germany, including the following market information:

Germany Anti-inflammatory Therapeutics Market Revenue, 2015-2020, 2021-2026, ($ millions)

Top Five Competitors in Germany Anti-inflammatory Therapeutics Market 2019 (%)

The global Anti-inflammatory Therapeutics market was valued at 100870 million in 2019 and is projected to reach US$ 126610 million by 2026, at a CAGR of 5.8% during the forecast period. While the Anti-inflammatory Therapeutics market size in Germany was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.

COVID-19 pandemic has big impact on Anti-inflammatory Therapeutics businesses, with lots of challenges and uncertainty faced by many players of Anti-inflammatory Therapeutics in Germany. This report also analyses and evaluates the COVID-19 impact on Anti-inflammatory Therapeutics market size in 2020 and the next few years in Germany


Total Market by Segment:

Germany Anti-inflammatory Therapeutics Market, By Type, 2015-2020, 2021-2026 ($ millions)

Germany Anti-inflammatory Therapeutics Market Segment Percentages, By Type, 2019 (%)

Anti-inflammatory Biologics

Non-Steroidal Anti-inflammatory Drugs (NSAIDs)

Corticosteroids

Others

On the basis of product type, anti-inflammatory biologics segment is projected to account for the largest revenue share during the forecast period; this segment was estimated to account for 58.35% revenue share in 2019, at a cagr of 6.54% in the forecast period.

Germany Anti-inflammatory Therapeutics Market, By Application, 2015-2020, 2021-2026 ($ millions)

Germany Anti-inflammatory Therapeutics Market Segment Percentages, By Application, 2019 (%)

Arthritis

Respiratory Diseases

Dermatology

Gastroenterology

Others

Arthritis accounted for over 42.41% global revenue share in 2019. And it is also show a fast growth rate of 6.60% in the next few years from 2020 to 2026.


Competitor Analysis

The report also provides analysis of leading market participants including:

Total Anti-inflammatory Therapeutics Market Competitors Revenues in Germany, by Players 2015-2020 (Estimated), ($ millions)

Total Anti-inflammatory Therapeutics Market Competitors Revenues Share in Germany, by Players 2019 (%)


Further, the report presents profiles of competitors in the market, including the following:

AbbVie

Johnson & Johnson

Amgen Inc

AstraZeneca PLC

Pfizer, Inc

Novartis

Roche

Merck

Sanofi

GlaxoSmithKline

Sun Pharmaceutical Industries Ltd